Research Associate I - Precision Oncology of Gastrointestinal Cancers jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 3 weeks ago

Research Associate I - Precision Oncology of Gastrointestinal Cancers

City of Hope is a transformative organization dedicated to fighting cancer and other life-threatening illnesses. They are seeking a Research Associate to join their multidisciplinary research team focused on the genomic and epigenomic characterization of gastrointestinal cancers, involving various laboratory research experiments and lab management responsibilities.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Maintain various aspects of lab management, including maintenance and upkeep of reagent and clinical specimen inventories, ordering, lab safety, and regulatory tasks
Ensure that all laboratory activities comply with each procedure(s) by utilizing safety procedures and guidelines in handling, storage, and disposal of bio-hazardous, infectious, and toxic material
Perform a variety of routine and non-routine laboratory research experiments and record and validate results for accuracy and completeness
Perform Cancer Genetics and Epigenetics techniques and general lab maintenance that assists in conducting an Investigator’s Research Project
Be responsible for accurately recording work performed, including results and methodology

Qualification

Molecular biology techniquesLaboratory managementFlow cytometryTissue cultureLab safety compliance

Required

Bachelor's or master's degree; master's degree preferred
Two years of laboratory experience with a bachelor's degree or 3 years of related research/ laboratory experience with a master's degree
Assist and perform various molecular biology techniques, such as tissue culture, flow cytometry (analysis), and molecular tests, according to the Laboratory's Standard Operating Procedures

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase